Quetiapine associated with angioedema
dc.authorid | 0000-0001-8401-4992 | |
dc.authorid | 0000-0001-9947-7690 | |
dc.contributor.author | Tuman, Taha Can | |
dc.contributor.author | Tuman, Bengü Altunay | |
dc.contributor.author | Şereflican, Betül | |
dc.contributor.author | Yıldırım, Osman | |
dc.date.accessioned | 2021-06-23T19:43:34Z | |
dc.date.available | 2021-06-23T19:43:34Z | |
dc.date.issued | 2016 | |
dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | To the Editors: Quetiapine is an atypical antipsychotic indicated for the treatment of schizophrenia and bipolar disorder, both manic and depressive episodes.1 Quetiapine is also widely used off label for treatment of various psychiatric disorders.2–4 Angioedema is characterized by swelling of deep dermis and subcutaneous tissues without itching, often seen around the eyes, lips, and genitals where subcutaneous tissue is loose.5 Histamine and bradykinin release by stimulation of mast cells via foods, drugs, infections, and physical stimuli lead to vascular permeability and dilatation. Drug-related angioedema is most commonly seen with ACE inhibitors and nonsteroidal antiinflammatory drugs.6 Here, we report a male patient with angioedema associated with quetiapine. | en_US |
dc.identifier.doi | 10.1097/JCP.0000000000000503 | |
dc.identifier.endpage | 290 | en_US |
dc.identifier.issn | 0271-0749 | |
dc.identifier.issn | 1533-712X | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 27035491 | en_US |
dc.identifier.scopus | 2-s2.0-84962097080 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 289 | en_US |
dc.identifier.uri | https://doi.org/10.1097/JCP.0000000000000503 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/8804 | |
dc.identifier.volume | 36 | en_US |
dc.identifier.wos | WOS:000375089900022 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Tuman, Taha Can | |
dc.institutionauthor | Şereflican, Betül | |
dc.institutionauthor | Yıldırım, Osman | |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal Of Clinical Psychopharmacology | en_US |
dc.relation.publicationcategory | Editöre Mektup - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Schizophrenia | |
dc.subject | Bipolar Disorder | |
dc.subject | Quetiapine | |
dc.subject | ACE Inhibitors | |
dc.subject | Angioedema | |
dc.title | Quetiapine associated with angioedema | en_US |
dc.type | Letter | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- Quetiapine_Associated_With_Angioedema.23.pdf
- Boyut:
- 98.01 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text